Literature DB >> 1676212

Topical salicylic acid interferes with UVB therapy for psoriasis.

B Kristensen1, O Kristensen.   

Abstract

Salicylic acid has been widely used in the topical treatment of psoriasis. Chemically it is closely related to paraaminobenzoic acid. Following in vitro studies indicating that salicylic acid might exhibit relevant UVB absorption, we found that salicylic acid had a clinically pronounced filter effect when applied prior to UVB exposure. The duration of photoprotection after application was more than 12 h, sometimes exceeding 24 h. In a prospective, randomized, double-blind, left-right comparison study in patients with psoriasis between emollients with and without salicylic acid, salicylic acid was shown to decrease the clearing rate significantly.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1676212

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  5 in total

Review 1.  [Maintenance therapy of psoriasis].

Authors:  J Wohlrab
Journal:  Hautarzt       Date:  2006-08       Impact factor: 0.751

2.  The effects of topically applied glycolic acid and salicylic acid on ultraviolet radiation-induced erythema, DNA damage and sunburn cell formation in human skin.

Authors:  Andrija Kornhauser; Rong-Rong Wei; Yuji Yamaguchi; Sergio G Coelho; Kays Kaidbey; Curtis Barton; Kaoruko Takahashi; Janusz Z Beer; Sharon A Miller; Vincent J Hearing
Journal:  J Dermatol Sci       Date:  2009-05-02       Impact factor: 4.563

3.  Applications of hydroxy acids: classification, mechanisms, and photoactivity.

Authors:  Andrija Kornhauser; Sergio G Coelho; Vincent J Hearing
Journal:  Clin Cosmet Investig Dermatol       Date:  2010-11-24

4.  Keratolytics and emollients and their role in the therapy of psoriasis: a systematic review.

Authors:  Arnd Jacobi; Anke Mayer; Matthias Augustin
Journal:  Dermatol Ther (Heidelb)       Date:  2015-01-21

5.  Single-center, noninterventional clinical trial to assess the safety, efficacy, and tolerability of a dimeticone-based medical device in facilitating the removal of scales after topical application in patients with psoriasis corporis or psoriasis capitis.

Authors:  Ulrich R Hengge; Kristina Röschmann; Henning Candler
Journal:  Psoriasis (Auckl)       Date:  2017-06-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.